Search

Author/Creator Cha, E

1. 1239TiPMORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types. (23rd October 2018)

Authors:
Chau, I; Haag, G M; Rahma, O E; Macarulla, T M; McCune, S L; Yardley, D A; Solomon, B J; Johnson, M; Vidal, G A; Schmid, P; Argiles, G; Dimick, K; Mahrus, S; Abdullah, H; He, X; Sayyed, P; Barak, H; Bleul, C; Cha, E; Drakaki, A
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors. (27th March 2019)

Authors:
Hellmann, M D; Kim, T -W; Lee, C B; Goh, B -C; Miller, W H; Oh, D -Y; Jamal, R; Chee, C -E; Chow, L Q M; Gainor, J F; Desai, J; Solomon, B J; Das Thakur, M; Pitcher, B; Foster, P; Hernandez, G; Wongchenko, M J; Cha, E; Bang, Y -J; Siu, L L
Journal:
Annals of oncology
Issue:
Volume 30:Number 7(2019)
Page Start:
1134
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗